512036 SKYBIOTECH

Skybiotech Healthcare Share Price

 

 

Start SIP in SKYBIOTECH

Start SIP

Performance

  • Low
  • ₹135
  • High
  • ₹140
  • 52 Week Low
  • ₹127
  • 52 Week High
  • ₹237
  • Open Price₹140
  • Previous Close₹140
  • Volume2,051
  • 50 DMA₹167.43
  • 100 DMA₹177.67
  • 200 DMA₹183.14

Investment Returns

  • Over 1 Month -15.79%
  • Over 3 Month -18.38%
  • Over 6 Month -32.22%
  • Over 1 Year -39.42%

Smart Investing Starts Here Start SIP with Skybiotech Healthcare for Steady Growth!

Invest Now

Skybiotech Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -14.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 27
  • P/B Ratio
  • 3.1
  • Average True Range
  • 6.69
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -12.09
  • RSI
  • 38.25
  • MFI
  • 85.67

Skybiotech Healthcare Financials

Skybiotech Healthcare Technicals

EMA & SMA

Current Price
₹138.95
-1 (-0.71%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹151.32
  • 50 Day
  • ₹167.43
  • 100 Day
  • ₹177.67
  • 200 Day
  • ₹183.14

Resistance and Support

137.97 Pivot Speed
  • R3 145.88
  • R2 142.92
  • R1 140.93
  • S1 135.98
  • S2 133.02
  • S3 131.03

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Skybiotech Healthcare Ltd has an operating revenue of Rs. 7.84 Cr. on a trailing 12-month basis. An annual revenue de-growth of -91% needs improvement, Pre-tax margin of -34% needs improvement, ROE of -26% is poor and needs improvement. The company has a debt to equity of 78%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 117 indicates it belongs to a poor industry group of Apparel-Clothing Mfg and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Skybiotech Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-28 Increase in Authorised Capital
2025-08-14 Quarterly Results
2025-05-30 Audited Results

Skybiotech Healthcare F&O

Skybiotech Healthcare Shareholding Pattern

63.48%
34.88%
1.64%

About Skybiotech Healthcare

  • NSE Symbol
  • SKYBIOTECH
  • BSE Symbol
  • 512036
  • Managing Director
  • Mrs. Poonam Rathi
  • ISIN
  • INE393H01016

Similar Stocks to Skybiotech Healthcare

Skybiotech Healthcare FAQs

Skybiotech Healthcare share price is ₹138 As on 14 February, 2026 | 21:36

The Market Cap of Skybiotech Healthcare is ₹26.6 Cr As on 14 February, 2026 | 21:36

The P/E ratio of Skybiotech Healthcare is -14.7 As on 14 February, 2026 | 21:36

The PB ratio of Skybiotech Healthcare is 3.1 As on 14 February, 2026 | 21:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23